Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

4.5%

1 terminated/withdrawn out of 22 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

14%

3 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

9 recruiting

Enrollment Performance

Analytics

Phase 1
4(33.3%)
Phase 4
3(25.0%)
Phase 2
3(25.0%)
N/A
2(16.7%)
12Total
Phase 1(4)
Phase 4(3)
Phase 2(3)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (22)

Showing 20 of 22 trials
NCT06947356Not ApplicableRecruiting

Comparison of TAF and TDF in Preventing Mother-to-Child Transmission of HBV in Pregnancies With High Viral Loads

Role: lead

NCT06916585Phase 2Not Yet Recruiting

Chinese Phase II Trail of AS1501 in Acute-on-chronic Liver Failure (ACLF) Patients

Role: collaborator

NCT04754139Not ApplicableCompleted

A Promotion and Implementation Project of HIV Pre-Exposure Prophylaxis Among High Risk Population

Role: collaborator

NCT06145841Recruiting

Metagenomic Next-Generation Sequencing Guides Anti-Infection Strategies

Role: lead

NCT06145828Recruiting

Clinical Application of Cytokine Adsorption Technique in AIDS Patients With Severe Pneumonia and/or Septic Shock

Role: lead

NCT06137196Recruiting

Risk Identification Factors for Pulmonary Function Impairment in AIDS Patients Recovered From Severe Pneumonia

Role: lead

NCT05988879Recruiting

Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients

Role: lead

NCT03884673Recruiting

Dolutegravir Plus Lamivudine Simplified Therapy

Role: lead

NCT03980665Phase 1Unknown

The Effect of Arsenic Trioxide on Eliminating HIV-1 Reservoir Combined With cART

Role: lead

NCT03240328Phase 1Recruiting

The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function

Role: lead

NCT04667026Recruiting

Observational Study on Patients With HIV/AIDS(OSPWH)

Role: lead

NCT03603977Recruiting

Simplified Treatment of Anti-retrovirus in China (C-STAR)

Role: lead

NCT05420246Unknown

Efficacy and Safety of Ainuovirine Treating With AIDS Patients

Role: lead

NCT05153005Unknown

Comprehensive Diagnosis and Treatment Strategy for Opportunistic Fungal Infections in AIDS Patients

Role: lead

NCT03980691Phase 1Completed

Effect of Chidamide Combined With CAT-T or TCR-T Cell Therapy on HIV-1 Latent Reservoir

Role: lead

NCT04252885Phase 4Completed

The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection

Role: lead

NCT04109183Phase 2Completed

A Drug Safety and Dose-exploratory Clinical Study of Azvudine Tablets in Patients Who Have Not Received Anti-HIV Treatment

Role: collaborator

NCT02563509Phase 1Completed

Reconstitution of HIV-specific Immunity Against HIV

Role: lead

NCT01600196Phase 4Terminated

Resection vs. Best Supportive Care for Hepatocellular Carcinoma (HCC) With Portal Venous Thrombus

Role: collaborator

NCT01521975Phase 4Completed

A Two-year Study of Telbivudine in HBeAg Negative Hepatitis

Role: collaborator